Andrew Rawdin
BSc (Sheffield Hallam), MRes (York)
Population Health, School of Medicine and Population Health
Health Economic Modeller
a.rawdin@sheffield.ac.uk
+44 114 222 0823
+44 114 222 0823
Regent Court (ScHARR)
Full contact details
Andrew Rawdin
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
Sheffield
S1 4DA
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
Sheffield
S1 4DA
- Profile
-
I joined ScHARR in 2006 after gaining a BSc in Mathematics at Sheffield Hallam University and an MRes in Mathematics and Ecology at the University of York.
- Research interests
-
My research interests are:
- Discrete event simulation modelling
- Health economic modelling
- Development of a formal framework for the validation of computer simulation models in health economics
- Economic modelling of Public Health interventions
- Population dynamics modelling in epidemic disease transmission
- Investigation of relationships between long term degenerative diseases and exposure to industrial pollutants.
I am currently working on the following projects:
- Economic effectiveness of pharmaceutical interventions for hepatocellular carcinoma
- The comparative economics effectiveness of different treatment methodologies for renal failure
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
- The clinical and cost effectiveness of group art therapy for people with non-psychotic mental health disorders: a systematic review and cost-effectiveness analysis. BMC Psychiatry, 15. View this article in WRRO
- Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 33(8), 833-847. View this article in WRRO
- Erratum to: The clinical and cost effectiveness of group art therapy for people with non-psychotic mental health disorders: a systematic review and cost-effectiveness analysis. BMC Psychiatry, 15(1). View this article in WRRO
- The cost-effectiveness of weight management programmes in a postnatal population. Public Health, 128(9), 804-810.
- A Rapid-Response Economic Evaluation of the UK NHS Cancer Reform Strategy Breast Cancer Screening Program Extension via a Plausible Bounds Approach. Value in Health, 13(2), 215-221.
- Thrombophilia testing in people with venous thromboembolism: systematic review and cost-effectiveness analysis.. Health technology assessment (Winchester, England), 13(2).
- The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review.. Health Technology Assessment, 16(20).
- Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review. Health Technology Assessment, 14(25).
- Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the treatment of osteoporotic vertebral fractures: a systematic review and cost-effectiveness analysis. Health Technology Assessment, 18(17).
- Routine echocardiography in the management of stroke and transient ischaemic attack: a systematic review and economic evaluation. Health Technology Assessment, 18(16).
All publications
Journal articles
- Non-invasive diagnosis of deep vein thrombosis from ultrasound imaging with machine learning. npj Digital Medicine, 4.
- Cost-effectiveness of vitamin D supplementation in pregnant woman and young children in preventing rickets: a modeling study. Frontiers in Public Health, 8. View this article in WRRO
- Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation. Health Technology Assessment, 24(29). View this article in WRRO
- An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values. Applied Health Economics and Health Policy, 17(3), 295-313. View this article in WRRO
- Pembrolizumab for Locally Advanced or Metastatic Urothelial Cancer Where Cisplatin is Unsuitable: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. View this article in WRRO
- Ponatinib for Treating Acute Lymphoblastic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 36(7), 759-768. View this article in WRRO
- Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 36(8), 903-915. View this article in WRRO
- The clinical effectiveness and Cost-Effectiveness of Treat-To-Target strategies in rheumatoid arthritis: A systematic review and cost-effectiveness analysis. Health Technology Assessment, 21(71), 1-258. View this article in WRRO
- A cost-effectiveness analysis of condom distribution programmes for the prevention of sexually transmitted infections in England.. Journal of Epidemiology and Community Health, 71, 897-904. View this article in WRRO
- Adalimumab for Treating Moderate-to-Severe Hidradenitis Suppurativa: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 35(8), 805-815. View this article in WRRO
- A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures. Health Technology Assessment, 20(78), 1-406. View this article in WRRO
- The clinical and cost effectiveness of group art therapy for people with non-psychotic mental health disorders: a systematic review and cost-effectiveness analysis. BMC Psychiatry, 15. View this article in WRRO
- Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 33(8), 833-847. View this article in WRRO
- Erratum to: The clinical and cost effectiveness of group art therapy for people with non-psychotic mental health disorders: a systematic review and cost-effectiveness analysis. BMC Psychiatry, 15(1). View this article in WRRO
- The cost-effectiveness of weight management programmes in a postnatal population. Public Health, 128(9), 804-810.
- A review of discrete event simulation in National Coordinating Centre for Health Technology Assessment-funded work and a case study exploring the cost-effectiveness of testing for thrombophilia in patients presenting with an initial idiopathic venous thromboembolism.. J. Simulation, 4, 14-23.
- A Rapid-Response Economic Evaluation of the UK NHS Cancer Reform Strategy Breast Cancer Screening Program Extension via a Plausible Bounds Approach. Value in Health, 13(2), 215-221.
- Thrombophilia testing in people with venous thromboembolism: systematic review and cost-effectiveness analysis.. Health technology assessment (Winchester, England), 13(2).
- Corrigendum: A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures. Health Technology Assessment, 20(78), 407-424. View this article in WRRO
- The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review.. Health Technology Assessment, 16(20).
- Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review. Health Technology Assessment, 14(25).
- Treat-to-Target Strategies in Rheumatoid Arthritis: a Systematic Review and Cost-Effectiveness Analysis. SN Comprehensive Clinical Medicine.
- Systematic review and economic modelling of the clinical effectiveness and cost-effectiveness of art therapy among people with non-psychotic mental health disorders. Health Technology Assessment, 19(18), 1-120. View this article in WRRO
- Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the treatment of osteoporotic vertebral fractures: a systematic review and cost-effectiveness analysis. Health Technology Assessment, 18(17).
- Routine echocardiography in the management of stroke and transient ischaemic attack: a systematic review and economic evaluation. Health Technology Assessment, 18(16).
Conference proceedings papers
- The Cost Effectiveness of Group Art Therapy for Patients with Non-Psychotic Mental Health Disorders in England And Wales. Value in Health, Vol. 17(7) (pp A458-A459)
- Clopidogrel is cost-effective compared with aspirin in United Kingdom patients with a myocardial infarction who subsequently sustain an ischaemic stroke or peripheral arterial disease event. VALUE HEALTH, Vol. 11(3) (pp A194-A195)
Posters
- Assessing the cost of parathyroidectomy as a treatment for uncontrolled secondary hyperparathyroidism in stage 5 chronic kidney disease.
- Cost effectiveness of group art therapy for patients with non-psychotic mental health disorders in England and Wales (2014).
Preprints
- Teaching interests
-
My teaching interests are:
- Supervising MSc dissertation projects
- Professional activities and memberships
-
I am a member of the ScHARR Marketing Committee